CARLSMED, INC.
CARL
Get informed when a big investor buys or sells
+ FollowMarket Cap$423.54M
Close$
Share Statistics
| Market cap | $423.54 Million |
|---|---|
| Enterprise Value | $399.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.12 |
| Beta | 1.94 |
| Outstanding Shares | 27,190,765 |
Return
| Return on Equity | -43.83% |
|---|---|
| Return on Assets | -31.24% |
| Return on Invested Capital | -29.63% |
Valuation & Multiples
| P/E Ratio | -11.46 |
|---|---|
| PEG | -20.7 |
| Price to Sales | 7.41 |
| Price to Book Ratio | 4.94 |
| Enterprise Value to Revenue | 6.31 |
| Enterprise Value to EBIT | -12.73 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
$17.95 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
$19.17 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 21.25%▲ 1.50% |
|---|---|
| Total Invested | $59.58M▲ 24.13% |
| Investors Holding | 77▲ 11.00% |
ESG Score
No data
About CARLSMED, INC.
100 employees
CEO: Michael John Cordonnier Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product ...